We’re All In for the Fight Against Cancer.
PTx is devoted to developing and commercializing cancer medicines and combination therapies that can make a meaningful difference in the lives of cancer patients. We are united in our passion for improving the treatment of cancer and our desire to make a meaningful contribution to outcomes.
Making a Difference is a Team Effort.
We believe that cancer is a complex, dynamic disease that requires a multi-faceted, multi-disciplinary approach. We believe in building collaborations to gain the expertise and experience necessary to cover the breadth and depth of the complex challenge that is cancer.
We work with leading companies and investigators to ensure that our products are tested in the best settings, and in combination with highest potential regimens, to maximize benefit to patients and advance the collective understanding of cancer treatment.
We seek to engage all members of the cancer treatment team from thought-leading physicians to the patient advocacy organizations. Our goal is to ensure that clear, complete, and balanced information about our products is proactively communicated and readily available. We work to support the extraordinary dedication of the medical teams that represent the front lines in the war on cancer.
The Patient is Our Priority.
We believe that being a cancer company begins and ends with the patient. We strive to support patients throughout their treatment journey and offer therapy options that are right for them and their loved ones.
Outcomes Are Our Yardstick
We believe that innovation is not enough. In today’s challenging healthcare climate, we strive to develop and assess our products based on the real-world impact they have in improving the quality and duration of our patients’ lives. We measure our success in the birthdays, anniversaries, and other important life moments that our patients are able to enjoy.
We also recognize the economic burden that cancer places on patients and their loved ones. Cancer also poses a challenge for hospitals and clinics as well as insurers under pressure to contain costs and keep premiums affordable. We believe in mitigating patient out-of-pocket costs through our support programs and we are committed to generating evidence of both the clinical and economic value of our products and combination therapies.